Centerline Biomedical Logo
  • Our Story
  • About
    • Leadership
    • Careers
  • Technology
    • IOPS Technology
    • IOPS Software
    • Viewpoint Catheters
    • Resources
  • News
  • Contact
Request a Demo
Centerline Biomedical Logo
  • Our Story
  • About
    • Leadership
    • Careers
  • Technology
    • IOPS Technology
    • IOPS Software
    • Viewpoint Catheters
    • Resources
  • News & Events
  • Contact
  • Request a Demo!
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer

Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer

by Steph Dunning | Aug 18, 2025 | News

CLEVELAND, Ohio., August 18, 2025 — Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of...
Occupational Hazards in Fluoroscopy-Guided Interventions

Occupational Hazards in Fluoroscopy-Guided Interventions

by Steph Dunning | Jul 31, 2025 | News

Fluoroscopy-guided procedures have transformed how interventionalists diagnose and treat vascular and cardiac conditions. While these advancements offer clear benefits to patients, they also introduce serious occupational risks for physicians and operating room staff....
Centerline Biomedical presentation from LSI USA ’25

Centerline Biomedical presentation from LSI USA ’25

by Steph Dunning | May 23, 2025 | News

Learn More about...
IOPS 3D Navigation Assists In Complex Endovascular Aneurysm Repair

IOPS 3D Navigation Assists In Complex Endovascular Aneurysm Repair

by Steph Dunning | May 16, 2025 | Case Study

LEAD CLINICIANDaniel Clair, M.D.Professor and Chair, Dept. of Vascular SurgeryVanderbilt University Medical Center (Nashville, Tennessee) PROCEDURE TYPE:Complex Endovascular Aneurysm Repair (EVAR) with Zenith Fenestrated Endovascular Graft (ZFen) BRIEF:A complex EVAR...
Growing market applications, Centerline Biomedical granted FDA 510(k) clearance for IOPS® with new, expanded indication for use

Growing market applications, Centerline Biomedical granted FDA 510(k) clearance for IOPS® with new, expanded indication for use

by Steph Dunning | Mar 11, 2025 | News

CLEVELAND, March 11, 2025 – Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance of expanded indications...
« Older Entries

Recent Posts

  • Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
  • Occupational Hazards in Fluoroscopy-Guided Interventions
  • Centerline Biomedical presentation from LSI USA ’25
  • IOPS 3D Navigation Assists In Complex Endovascular Aneurysm Repair
  • Growing market applications, Centerline Biomedical granted FDA 510(k) clearance for IOPS® with new, expanded indication for use

Recent Comments

  • $578 million for Greater Cleveland’s startups: These 23 companies raised the most cash in 2022 - Fox 18 News on Centerline Biomedical Raises $33 Million in Series B Financing
  • A Cleveland Startup is Making Surgery Safer – TechOhio on TechOhio Founder Story: Centerline Biomedical
  • Ohio startups raised $500 million in Q2: See which Greater Cleveland companies made big deals - Ohio Digital News on Centerline Biomedical Raises $33 Million in Series B Financing
  • GE Healthcare propulse la scission d'imagerie de Cleveland Clinic à un tour de financement de 33 millions de dollars - Nouvelles Du Monde on Centerline Biomedical Raises $33 Million in Series B Financing

© 2025 Centerline Biomedical

  • Terms of Use
  • Privacy Policy
  • FCOI Policy
  • Indications for Use
  • Follow
  • Follow
  • Follow
  • Terms of Use
  • Privacy Policy
  • FCOI Policy
  • Indications for Use
  • Follow
  • Follow
  • Follow

© 2025 Centerline Biomedical